Acetarsol-induced Stevens-Johnson syndrome

KLAASSEN CD . Heavy metal and heavy-metal antagonists. In: Gilman AG , Goodman LS , Rall TW , Murad F eds. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed. New York: Macmillan, 1985: 1605–27.

DOMONCOS AN , ARNOLD HL Jr , ODOM RB . Andrews’ diseases of the skin. 7th ed. Philadelphia: WB Saunders, 1982: 115–41.

PARRISH JA , FITZPATRICK TB , TANENBAUM L Photochemotherapy of psoriasis with oral methoxsalen and ultraviolet light. N Engl J Med 1974; 291: 1207–11.

CLAXTON RC . A review of 31 cases of Stevens-Johnson syndrome. Med J Aust 1963; 50: 963–72.

WILSON EE , MALINAK LR . Vulvovaginal sequelae of Stevens-Johnson syndrome and their management. Obstet Gynecol 1988; 71: 478–80.

KAMPMEIER RH . Syphilis therapy, an historical perspective. J Am Vener Dis Assoc 1976; 3: 99–108.

BERGGREN L. Acetarsol—an organic compound with toxic effect on the optic nerve. Lakartidningen 1988; 17: 521–3.

RASMUSSEN JE . Erythema multiforme in children: response to treatment with systemic corticosteroid. Br J Dermatol 1976; 95: 181–6.

DISANTIS GJ , FLANAGAN J. Minoxidil-induced Stevens-Johnson syndrome. Arch Intern Med 1981; 141: 1515.